Assessment of Response of Kidney Tumors to Rapamycin and Atorvastatin in Tsc1+/− MiceMing Hong Shen(Cardiff University), Julian R. Sampson(Cardiff University)Translational OncologyAugust 24, 201710.1016/j.tranon.2017.07.009Cited by 2SaveCiteExport RISWatch citationsRelated PapersRenal tumours in a Tsc2+/− mouse model do not show feedback inhibition of Akt and are effectively prevented by rapamycin|Oncogene|2014|16